ÂÜÀòÂÒÂ×

Anna Attman Lennegren is a seasoned marketing professional with extensive experience in innovation and brand management within the consumer healthcare industry. Currently serving as the Global Innovation Marketing Manager for Skin Health at Karo Healthcare, Anna is responsible for managing the global innovation growth agenda and product pipeline for notable brands such as Lamisil and E45. Previous roles include Innovation Manager for OTC at Haleon and GSK, where Anna managed large OTC portfolios in Northern Europe, as well as strategizing for brand growth and commercial integration following acquisitions. Earlier career highlights include leadership positions at Novartis Consumer Health and Unilever, with a solid foundation in marketing and product management across various categories. Anna holds a Bachelor of Science in International Business Administration and Economics from the University of Gothenburg.